Management of Watery Diarrhea in Patients with Diabetes
Initial Assessment and Management
- The American College of Physicians recommends assessing hydration status and providing appropriate fluid replacement in patients with watery diarrhea, with a goal of preventing dehydration 1, 2
- A BRAT diet (Bananas, Rice, Applesauce, Toast) is recommended to help reduce stool frequency in patients with watery diarrhea 1
Pharmacological Management
- Loperamide is recommended as the first-line treatment for slowing down watery diarrhea in patients with diabetes, with an initial dose of 4 mg followed by 2 mg after each loose stool, not exceeding 16 mg daily, as suggested by the National Comprehensive Cancer Network 1
- Diphenoxylate/atropine may be considered as an alternative option for patients with watery diarrhea, at a dose of 1-2 tablets PO every 6 hours as needed, maximum 8 tablets/day, according to the National Comprehensive Cancer Network 1
- Anticholinergic agents, such as hyoscyamine and atropine, may be used for persistent symptoms of watery diarrhea, with dosages of 0.125 mg PO/ODT/SL every 4 hours PRN and 0.5-1 mg subcutaneous, IM, IV, or SL every 4-6 hours as needed, respectively, as recommended by the National Comprehensive Cancer Network 1
Hydration Therapy
- Oral hydration and electrolyte replacement are recommended for patients with watery diarrhea, with a goal of preventing dehydration, as suggested by the National Comprehensive Cancer Network and the Annals of Oncology 1, 2
- Oral rehydration solutions (ORS) containing 65-70 mEq/L sodium and 75-90 mmol/L glucose are recommended for mild to moderate dehydration, according to the Annals of Oncology 2
- IV fluids may be necessary for severe dehydration or if patients are unable to tolerate oral fluids, as recommended by the Annals of Oncology and Clinical Infectious Diseases 2, 3
- Ongoing fluid losses should be replaced, with approximately 10 mL/kg for each watery stool, as suggested by the MMWR Recommendations and Reports 4, 5
Treatment Escalation for Persistent Symptoms
- For persistent Grade 2-4 diarrhea, octreotide may be considered at a dose of 100-500 mcg/day subcutaneous or IV, every 8 hours or by continuous infusion, as recommended by the National Comprehensive Cancer Network and the Annals of Oncology 1, 6